Y-mAbs Therapeutics Added to the NASDAQ Biotechnology Index tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Shares of Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB – Get Free Report) have been given an average recommendation of “Hold” by the nine ratings firms that are currently covering the firm, MarketBeat.com reports. Two equities research analysts have rated the stock with a sell rating, three have given a hold rating and four have given a buy […]
Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB – Get Free Report) Director Johan Wedell-Wedellsborg purchased 62,516 shares of the stock in a transaction that occurred on Monday, November 27th. The shares were purchased at an average price of $5.49 per share, with a total value of $343,212.84. Following the completion of the acquisition, the director now directly owns […]
HC Wainwright reiterated their buy rating on shares of Y-mAbs Therapeutics (NASDAQ:YMAB – Free Report) in a research note released on Wednesday, Benzinga reports. The brokerage currently has a $11.00 price target on the stock. HC Wainwright also issued estimates for Y-mAbs Therapeutics’ FY2023 earnings at ($0.65) EPS, Q1 2024 earnings at ($0.19) EPS, Q2 […]
Shares of Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB – Get Free Report) have earned an average rating of “Hold” from the ten analysts that are covering the firm, Marketbeat Ratings reports. Two research analysts have rated the stock with a sell recommendation, four have given a hold recommendation and four have issued a buy recommendation on the […]